about
Novel role of phosphodiesterase inhibitors in the management of end-stage heart failureConduction abnormalities and ventricular arrhythmogenesis: The roles of sodium channels and gap junctions'Ryanopathy': causes and manifestations of RyR2 dysfunction in heart failureClinical Potentials of Cardiomyocytes Derived from Patient-Specific Induced Pluripotent Stem CellsFormation of spatially discordant alternans due to fluctuations and diffusion of calciumSilent disease progression in clinically stable heart failure.Deletion of CXCR4 in cardiomyocytes exacerbates cardiac dysfunction following isoproterenol administrationActive inhibitor-1 maintains protein hyper-phosphorylation in aging hearts and halts remodeling in failing hearts.Polycystin-1 Is a Cardiomyocyte Mechanosensor That Governs L-Type Ca2+ Channel Protein StabilityNicotinic Acid Adenine Dinucleotide Phosphate (NAADP) and Cyclic ADP-Ribose (cADPR) Mediate Ca2+ Signaling in Cardiac Hypertrophy Induced by β-Adrenergic Stimulation.A Decoy Peptide Targeted to Protein Phosphatase 1 Attenuates Degradation of SERCA2a in Vascular Smooth Muscle Cells.How to build an integrated biobank: the Washington University Translational Cardiovascular Biobank & Repository experience.Myofilament dysfunction as an emerging mechanism of volume overload heart failure.Phospholamban Inhibition by a Single Dose of Locked Nucleic Acid Antisense Oligonucleotide Improves Cardiac Contractility in Pressure Overload-Induced Systolic Dysfunction in Mice.From Bench to Bedside: New Approaches to Therapeutic Discovery for Heart FailureArrhythmogenic and metabolic remodelling of failing human heart.Rapid effects of aldosterone in primary cultures of cardiomyocytes - do they suggest the existence of a membrane-bound receptor?Systolic [Ca2+ ]i regulates diastolic levels in rat ventricular myocytes.Trigger vs. Substrate: Multi-Dimensional Modulation of QT-Prolongation Associated Arrhythmic Dynamics by a hERG Channel Activator.The cardiac L-type calcium channel alpha subunit is a target for direct redox modification during oxidative stress-the role of cysteine residues in the alpha interacting domain.Sensitivity analysis revealing the effect of modulating ionic mechanisms on calcium dynamics in simulated human heart failure.Management of Arrhythmias in Heart Failure.
P2860
Q26741100-DD5D6DE7-0C24-4318-9DCD-07A68E5B7D88Q26769921-D45E9ABF-DD2B-44E5-A1C0-A1C89C785EC8Q26865421-0B171F4B-8914-4E6E-83B5-7731854AE81EQ27021919-64AFF739-75E0-42F3-99DF-78FB0D058B21Q27333903-B72896F6-58F9-4304-9A12-2B6BFAAB1DE2Q33578212-CB262F9E-DE84-4176-929C-19A69C9381DEQ33590761-E2608C92-C531-443B-8C06-C1DAEA8F8514Q35061110-CB221A68-AEFA-4F52-9066-E5EE90EEA4FDQ35752234-E061A0FF-4A94-43C6-97B3-E20238112369Q35950983-9B4ED5C9-B0B2-4575-9366-B08678A88E68Q36177187-A0C49DD0-AD70-42C9-8ED7-28C9DFF01617Q36929336-10555AAA-7355-4BD9-B48F-CAB65A51686EQ38184400-73CB07BA-73C0-4DE1-B308-FEE11236F7E1Q38290254-E59411C8-02A0-4A90-8D6E-4136B678CEF0Q38780801-BF295FC6-EDED-4F2E-A18A-FD9DB1C70F37Q38790941-AEFC388E-5366-4021-A279-685EDB4776B8Q39681256-D2C001AF-6EE8-4841-A295-09DF30565D5AQ41389375-A29367A2-42AC-48A0-9CC1-1BA94FA08CDEQ42372777-5738F87B-E2BB-4BDC-9044-062127594CEDQ46402706-92DCD4D5-CB8D-4A7C-9951-80AFC48FF984Q46943331-6D147F1E-CF4E-4B83-8A99-43EBE5F7D5FAQ55315730-25927CAC-0C4B-40CF-8842-B1BDBDFF59B4
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Remodeling of calcium handling in human heart failure.
@en
Remodeling of calcium handling in human heart failure.
@nl
type
label
Remodeling of calcium handling in human heart failure.
@en
Remodeling of calcium handling in human heart failure.
@nl
prefLabel
Remodeling of calcium handling in human heart failure.
@en
Remodeling of calcium handling in human heart failure.
@nl
P2093
P2860
P1476
Remodeling of calcium handling in human heart failure.
@en
P2093
Ajit Janardhan
Igor R Efimov
P2860
P304
P356
10.1007/978-94-007-2888-2_52
P407
P577
2012-01-01T00:00:00Z